Preliminary Risk Assessment for Acrylamide and Peripheral Neuropathy
Public Domain
-
2021/07/01
-
By Park RM
Details
-
Personal Author:
-
Description:Acrylamide (ACM) is a high-volume industrial chemical with diverse uses in manufacturing, construction and laboratory research. ACM is a well-established neurotoxic agent causing peripheral neuropathy with impairment in the arms and legs of exposed workers, most thoroughly studied in Swedish tunnel workers exposed to ACM grouting. A quantitative risk assessment was performed to assess ACM risk to workers. Using data from a published paper investigating peripheral neuropathies in Chinese chemical workers, estimates of exposure response for vibration perception threshold and nerve conduction velocities were calculated, based on hemoglobin adducts and air concentrations as exposure metrics. The benchmark dose procedure was applied in order to calculate excess risks of impairment, defined as adverse performance exceeding the 95th percentile in unexposed populations, at various concentrations of airborne ACM exposure. Under the assumptions in this risk assessment, after three years of inhalation exposure at 0.3 mg/m3 , the excess attributable impairment manifest in vibration perception and nerve conduction velocity is estimated to occur in 1-2% of workers. For 10 years at 0.3 mg/m3 ACM inhalation (equivalent to 3 years at 1.0 mg/m3) the excess prevalence of impairment would be 2-14% of workers, assuming the effect continues to accrue linearly in time. Using published data, the risks of impairment from peripheral neuropathy attributable to exclusively airborne ACM exposure can be predicted for exposure periods less than 10 years. The risks associated with dermal and airborne ACM exposures can be estimated by characterizing working process environments using ACM Hb-adduct levels and possibly monitored with urinary biomarkers. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0161-813X
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:10-17
-
Volume:85
-
NIOSHTIC Number:nn:20062749
-
Citation:Neurotoxicology 2021 Jul; 85:10-17
-
Contact Point Address:Robert M. Park, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health (NIOSH), Division for Science Integration, Risk Evaluation Branch, 1090 Tusculum Ave, MS C-15, Cincinnati, OH 45226-1998
-
Email:rhp9@cdc.gov
-
CAS Registry Number:
-
Federal Fiscal Year:2021
-
Peer Reviewed:True
-
Source Full Name:Neurotoxicology
-
Collection(s):
-
Main Document Checksum:urn:sha-512:f68fb24872546fd9d81c39690e2cb49d0f2c5318039ce57d17d249fa1a7280422882f3434ee5ef2fb09243a27c5db804cffac0576d937a5fd8fae8e83d9fdb2b
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like